WEL Research Institute
Walloon ExceLlence Research Institute
Supporting strategic basic research of excellence and the translation of disruptive innovations into an impact in health and sustainable transition.
News & Events
News
Publication in Nature Cardiovascular Research
Treatment of vascular malformation in utero
From bench to bedside: How an understanding of the mechanisms of vascular development in Miikka Vikkula's lab led to the prenatal treatment of a foetus suffering from a lymphatic malformation by Dr Laurence Boon's team.
News
Publication in Nature Communications
Elucidating how mutations in calreticulin induce blood cancer
For 20 years, Stefan Constantinescu's team has been trying to establish the molecular basis of certain blood cancers (myeloproliferative neoplasms) with several discoveries to their credit.
News
Publication in Microbiome
Influence of the gut microbiota on eating behaviour
Amandine Everard's team demonstrated a causal link between the intestinal microbiota, and more precisely a phenolic metabolite produced by it, and compulsive eating behaviours.
Lines of work
Strategic fundamental research
The WEL Research Institute supports strategic basic research through programmes emanating from the universities of the Wallonia-Brussels Federation. Their selection and financial management are carried out via the FRFS, a specialised fund of the FNRS.
Industrial valorisation
The WEL Research Institute provides individualised support for researchers, in partnership with KTO representatives, to integrate the valorisation process into the scientific development of the research programme.
The "Bridge Fund"
The Bridge Fund provides funding for a maturation stage of intellectual property emanating from the WEL Research Institute's programmes to reach the next stage of technology transfer.
Partnerships
The WEL Research Institute has gradually built valorization opportunities that are taking many forms including projects supported by the competitivity clusters, licensing agreements, industry partnerships, and spin-off creation.
No result.
Our partners
